Federal Register Notice: FDA’s collection of information entitled “Guidance for Industry on User Fee Waivers, Reductions, and Refunds for Drug and Biological Products,” has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. To view this notice, click here.
